Publication | Closed Access

Hexacosanol reduces plasma and hepatic cholesterol by activation of AMP-activated protein kinase and suppression of sterol regulatory element-binding protein-2 in HepG2 and C57BL/6J mice

InflammationHepatic CholesterolOxysterolHepatologyBiochemistryCell SignalingLiver PhysiologyAmp-activated Protein KinaseMedicineC57bl/6j MiceHepatotoxicityPharmacologyAtherosclerosisLipid Synthesis